Hodgkin lymphoma trials in Australia

In Australia 11 Also abroad 155

11 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
East Melbourne
Age
18 years and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
Phase 1/2Taking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Adelaide, Box Hill, Townsville
Age
18 years and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Macquarie University, Melbourne, Nedlands, Randwick
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 1Taking people
A Study of ARC-02 in B-cell NHL
Where
Clayton, Melbourne, Nedlands, Southport
Age
18 years and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Heidelberg, Kogarah, Macquarie University, Nedlands
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
Phase 1/2Taking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Adelaide, Birtinya, Fitzroy, Nedlands, South Brisbane, Waratah
Age
12 years and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
Phase 1Taking people
A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Where
Melbourne
Age
6 years to 25 years
People
10
Run by
Murdoch Childrens Research Institute
See details and how to joinNCT06383338
Phase 3Taking people
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Where
Adelaide, Box Hill, Brisbane, Darwin, Liverpool, Melbourne, Saint Leonards, Sydney, Townsville
Age
16 years to 69 years
People
1,042 worldwide
Run by
University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00
Phase 2/3Taking people
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Where
Brisbane, Perth, Sydney
Age
Up to 25 years
People
210 worldwide
Run by
University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00
Phase 2Taking people
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Where
Adelaide, Concord, Heidelberg, Nowra, Perth, Wollongong
Age
18 years and over
People
84 worldwide
Run by
Canadian Cancer Trials Group
See details and how to joinNCT05180097
Phase 1Taking people
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Where
Sydney, Westmead
Age
1 year to 21 years
People
54 worldwide
Run by
Therapeutic Advances in Childhood Leukemia Consortium
See details and how to joinNCT05476770